Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Pediatr Blood Cancer ; 71(7): e31004, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38637875

RESUMO

Pleuroparenchymal fibroelastosis (PPFE) is a rare interstitial pneumonia with distinct clinicopathologic features. It has been associated with exposure to hematopoietic stem cell transplantation (HSCT) and classical alkylating agents. Here, we highlight PPFE as a late complication of childhood cancer therapy by describing the cases of four survivors of childhood cancer with a diagnosis of treatment-related PPFE. All patients received high-dose alkylating agents. PPFE should be considered in the differential diagnosis of restrictive lung disease in patients with history of exposure to alkylating agents or HSCT. Development of PPFE-specific, noninvasive diagnostic tools and disease-modifying therapies will clinically benefit these patients.


Assuntos
Doenças Pulmonares Intersticiais , Adolescente , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Antineoplásicos Alquilantes/efeitos adversos , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Doenças Pulmonares Intersticiais/patologia , Doenças Pulmonares Intersticiais/etiologia , Doenças Pulmonares Intersticiais/induzido quimicamente , Doenças Pulmonares Intersticiais/terapia , Neoplasias/tratamento farmacológico , Neoplasias/complicações , Neoplasias/patologia , Fibrose Pulmonar/etiologia , Fibrose Pulmonar/patologia
2.
JCO Oncol Pract ; 18(9): e1505-e1512, 2022 09.
Artigo em Inglês | MEDLINE | ID: mdl-35749678

RESUMO

PURPOSE: As the role of clinical ethics consultation in health care advances, there are calls to standardize the process of consultation. The Ethics Committee at Memorial Sloan Kettering Cancer Center (MSK) hypothesized that the process of requesting an ethics consultation could be improved by instituting an electronic health record (EHR) order for consultation requests. This report summarizes the impact of adopting an EHR order for ethics consultation requests at MSK. METHODS: This retrospective review of all clinical ethics consultations requested at a tertiary cancer center from May 2017 to February 2020 spans 17 months before and after implementation of an electronic order for consultation requests. Summary statistics are presented using Pearson chi-square analyses with a significance level of 0.05. RESULTS: There was a significant increase in the total number of consultation requests placed after implementation of the EHR order (n = 165, 0.08% of total patients) compared with before (n = 108, 0.05% of total patients; P = .007). The number of consults requested by providers from inpatient (P = .02) and outpatient (P = .04) settings significantly increased. The proportion of consults placed by medical versus nonmedical providers remained unchanged (P = .32). CONCLUSION: In this large single-institution retrospective study, implementation of an EHR order for ethics consultation requests was associated with a significant increase in the number of consultation requests. Implementation of an electronic order may decrease barriers to ethics consultation in diverse practice settings. Further longitudinal, multicenter studies are needed to assess strategies to improve access to clinical ethics consultation for oncology patients.


Assuntos
Consultoria Ética , Atenção à Saúde , Registros Eletrônicos de Saúde , Comissão de Ética , Humanos , Estudos Retrospectivos
3.
Ophthalmic Genet ; 43(6): 806-808, 2022 12.
Artigo em Inglês | MEDLINE | ID: mdl-36695494

RESUMO

Since 2006, ophthalmic artery chemosurgery (OAC) has been used for ocular-sparing treatment of retinoblastoma. Systemic exposure to melphalan is known to cause ovarian dysfunction, but the effect of melphalan-based OAC has not yet been determined. Here, we assess biochemical and symptomatic measures of ovarian function in a cohort of pubertal female survivors of retinoblastoma treated with melphalan-based OAC. These 13 patients all had normal gonadotropins at a median age of 11.1 years, 9.6 years from the completion of therapy. None had symptoms of ovarian dysfunction. This study provides initial evidence that ovarian function remains intact after melphalan-based OAC.


Assuntos
Neoplasias da Retina , Retinoblastoma , Humanos , Feminino , Lactente , Criança , Retinoblastoma/tratamento farmacológico , Retinoblastoma/cirurgia , Melfalan/efeitos adversos , Neoplasias da Retina/tratamento farmacológico , Carboplatina/uso terapêutico , Eletrorretinografia , Topotecan , Resultado do Tratamento , Infusões Intra-Arteriais , Estudos Retrospectivos , Sobreviventes , Artéria Oftálmica/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA